CoChat

Gestational Diabetes Mellitus in Early Pregnancy: Evidence for Poor Pregnancy Outcomes Despite Treatment

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Recent guidelines recommend testing at <24 weeks of gestation for maternal dysglycemia in “high-risk” women. Evidence to support the early identification and treatment of gestational diabetes mellitus (GDM) is, however, limited. We examined the prevalence, clinical characteristics, and pregnancy outcomes of high-risk women with GDM diagnosed at <24 weeks of gestation (early GDM) and those with pre-existing diabetes compared with GDM diagnosed at ≥24 weeks of gestation, in a large treated multiethnic cohort. RESEARCH DESIGN AND METHODS: Outcomes from 4,873 women attending a university hospital antenatal diabetes clinic between 1991 and 2011 were examined. All were treated to standardized glycemic targets. Women were stratified as pre-existing diabetes (n = 65) or GDM diagnosed at <12 weeks of gestation (n = 68), at 12–23 weeks of gestation (n = 1,247), or at ≥24 weeks of gestation (n = 3,493). RESULTS: Hypertensive disorders in pregnancy including pre-eclampsia, preterm delivery, cesarean section, and neonatal jaundice (all P < 0.001) were more prevalent in women with pre-existing diabetes and early GDM. Macrosomia (21.8% vs. 20.3%, P = 0.8), large for gestational age (39.6% vs. 32.8%, P = 0.4), and neonatal intensive care admission (38.5% vs. 39.7%, P = 0.9) in women in whom GDM was diagnosed at <12 weeks of gestation were comparable to rates seen in women with pre-existing diabetes. CONCLUSIONS: Despite early testing and current best practice treatment, early GDM in high-risk women remains associated with poorer pregnancy outcomes. Outcomes for those in whom GDM was diagnosed at <12 weeks of gestation approximated those seen in pre-existing diabetes. These findings indicate the need for further studies to establish the efficacy of alternative management approaches to improve outcomes in these high-risk pregnancies.

Overview

Integrity signals

Registry

Crossref · 10.2337/dc15-0433

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 37 references

Research works printed but not linked: 1

  1. Barker, 1994, Mothers, Babies and Diseases in Later Life

Cited by

Metadata

Authors
Sweeting, A. N., Ross, G. P., Hyett, J., Molyneaux, L., Constantino, M., Harding, A. J., & Wong, J.
Affiliations
  • The University of Sydney (AU)
  • Royal Prince Alfred Hospital (AU)
Corresponding author
Sweeting, Arianne N.
Venue
Diabetes Care
Published
2015-12-05
Volume
39
Issue
1
Pages
75-81
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2209588964
Cited by
263
References
36
Citations by year
2026: 12 · 2025: 24 · 2024: 32 · 2023: 30 · 2022: 33 · 2021: 30 · 2020: 40 · 2019: 22 · 2018: 21 · 2017: 10 · 2016: 8
FWCI
14.75
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
gestational diabetes mellitus, early pregnancy diagnosis, pregestational diabetes, high-risk pregnancy, glycemic control, hypertensive disorders of pregnancy, preeclampsia, preterm birth, cesarean section, neonatal jaundice, macrosomia, large for gestational age, neonatal intensive care admission, pregnancy outcomes
MeSH terms
Adult, Birth Weight, Blood Glucose, Cesarean Section, Female, Fetal Macrosomia, Humans, Infant, Newborn, Jaundice, Neonatal, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Cohort Studies, Diabetes, Gestational, Premature Birth

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.